Certain Common Stock of Monterey Bio Acquisition Corporation are subject to a Lock-Up Agreement Ending on 30-MAR-2022.
Details:
Certain number of founder shares and private warrants will be considered underwriting compensation in connection with this offering. Such founder shares and private warrants will be subject to lock-up restrictions, as required by finra rule 5110(e)(1) and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of effectiveness of the registration statement.